Aurigene Oncology

Clinical-stage cancer biotech in Bengaluru running small-molecule and peptide discovery, from target validation to clinical candidates.

Location: Bengaluru, India

1 model(1 Small molecule, 1 Protein)

Models (1)

Indraprastha Institute of Information Technology Delhi / Aurigene Oncology

Released August 28, 2025

———

Protein degrader design framework that mines fragment-target data to build PROTACs and predicts degradation potency (DC50) and maximal degradation.

Small moleculeProtein